In this context, a number of studies already demonstrated a positive correlation between SST2 expression in GH-secreting tumor cells and fg-SRL efficacy in reducing hormone secretion both in vitro and in vivo [9,10,11,12,13,14]. This evidence concerns the gene GH1 and neoplasm.